Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Therapeutics - Page 64

Therapeutics

Karmanos researcher Patricia LoRusso appointed co-leader of the Stand Up To Cancer Dream Team
Biotechnology | Diagnostics | Disease | Genomics | Non-Profit Research | Oncology | Therapeutics

Karmanos researcher Patricia LoRusso appointed co-leader of the Stand Up To Cancer Dream Team

On Dec. 14, 2011, Patricia M. LoRusso, D.O., of the Barbara Ann Karmanos Cancer Institute in Detroit, Michigan;…

Read More Karmanos researcher Patricia LoRusso appointed co-leader of the Stand Up To Cancer Dream TeamContinue

Washington University’s Genome Institute received $114 million grant
Biotechnology | Genomics | Non-Profit Research | Therapeutics

Washington University’s Genome Institute received $114 million grant

On Dec. 6, 2011, Washington University’s Genome Institute received a four-year $114 million grant from the National Human…

Read More Washington University’s Genome Institute received $114 million grantContinue

The CDC activated the Emergency Operations Center to support the global polio eradication effort
Biotechnology | CDC | Infectious Disease | NIH | Non-Profit Research | Polio | Therapeutics

The CDC activated the Emergency Operations Center to support the global polio eradication effort

On Dec. 2, 2011, the U.S. Centers for Disease Control and Prevention (CDC) Director Thomas R. Frieden, MD,…

Read More The CDC activated the Emergency Operations Center to support the global polio eradication effortContinue

MUSC dedicated new bioengineering and drug discovery hubs
Biotechnology | Medical Device | Non-Profit Research | Therapeutics | U.S. Congress

MUSC dedicated new bioengineering and drug discovery hubs

On Oct. 24, 2011, the Medical University of South Carolina (MUSC) officially dedicated the James E. Clyburn Research…

Read More MUSC dedicated new bioengineering and drug discovery hubsContinue

The OHSU/OSU Collaborative Life Sciences Building broke ground
Biotechnology | Dentistry | Diagnostics | Medicine | Non-Profit Research | Therapeutics

The OHSU/OSU Collaborative Life Sciences Building broke ground

On Oct. 13, 2011, the OHSU/OSU Collaborative Life Sciences Building (CLSB) broke ground on the new $295 million…

Read More The OHSU/OSU Collaborative Life Sciences Building broke groundContinue

The CDC responded to a multi-state outbreak of listeriosis
Biotechnology | CDC | Infectious Disease | NIH | Non-Profit Research | Therapeutics

The CDC responded to a multi-state outbreak of listeriosis

On Sept. 30, 2011, the U.S. Centers for Disease Control and Prevention (CDC) responded to a multi-state outbreak…

Read More The CDC responded to a multi-state outbreak of listeriosisContinue

Mayo Clinic announced plans to open a medical school in Scottsdale, Arizona
Biotechnology | Diagnostics | Disease | Medicine | Non-Profit Research | Therapeutics

Mayo Clinic announced plans to open a medical school in Scottsdale, Arizona

On Sept. 27, 2011, the Mayo Clinic announced a $120 million plan to open its first medical school…

Read More Mayo Clinic announced plans to open a medical school in Scottsdale, ArizonaContinue

The Monroe Cancer Center opened
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Radiology | Therapeutics

The Monroe Cancer Center opened

On Sept. 2, 2011, the Monroe Cancer Center opened as a joint venture between Karmanos Cancer Institute, Mercy…

Read More The Monroe Cancer Center openedContinue

Stanford/Packard scientists found new uses for existing drugs by mining gene-activity data banks
Biotechnology | Diagnostics | Disease | Therapeutics

Stanford/Packard scientists found new uses for existing drugs by mining gene-activity data banks

On Aug. 17, 2011, Stanford/Packard scientists found new uses for existing drugs by mining gene-activity data banks. When…

Read More Stanford/Packard scientists found new uses for existing drugs by mining gene-activity data banksContinue

Genentech drug Zelboraf (vemurafenib) was approved
Biotechnology | FDA | Life Science History | Oncology | Therapeutics

Genentech drug Zelboraf (vemurafenib) was approved

On Aug. 16, 2011, the U.S. Food and Drug Administration (FDA) approved vemurafenib tablets (Zelboraf, Hoffmann-LaRoche Inc.) for…

Read More Genentech drug Zelboraf (vemurafenib) was approvedContinue

Genomeon was established under the laws of the Commonwealth of Virginia
Biotechnology | Diagnostics | Genomics | Life Science History | Medicine | Therapeutics

Genomeon was established under the laws of the Commonwealth of Virginia

On Aug. 11, 2011, Genomeon was established under the laws of the Commonwealth of Virginia by Dr. Harold…

Read More Genomeon was established under the laws of the Commonwealth of VirginiaContinue

Siteman Cancer Center performed its 5,000th bone marrow transplant
Disease | Life Science History | Medicine | Non-Profit Research | Oncology | Radiology | Therapeutics

Siteman Cancer Center performed its 5,000th bone marrow transplant

On Aug. 9,  2011, the Siteman Cancer Center announced that it had performed its 5,000th bone marrow transplant,…

Read More Siteman Cancer Center performed its 5,000th bone marrow transplantContinue

The Maine Institute for Human Genetics and Health discontinued operations
Biotechnology | Diagnostics | Disease | Therapeutics

The Maine Institute for Human Genetics and Health discontinued operations

On Jul. 17, 2011, the Maine Institute for Human Genetics and Health announced that it would cease operations…

Read More The Maine Institute for Human Genetics and Health discontinued operationsContinue

Genome for endangered Tasmanian tiger was completed
Biotechnology | Disease | Genomics | Life Science History | Oncology | Therapeutics

Genome for endangered Tasmanian tiger was completed

On Jun. 28, 2011, to prevent extinction of the Tasmanian tiger, a team of scientists led by the…

Read More Genome for endangered Tasmanian tiger was completedContinue

TomoTherapy acquired by Accuray
Biotechnology | Oncology | Radiology | Therapeutics

TomoTherapy acquired by Accuray

On Jun. 13, 2011, Accuray announced it had completed its acquisition of TomoTherapy. The combination creates the premier…

Read More TomoTherapy acquired by AccurayContinue

University Hospitals Seidman Cancer Center opened
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Radiology | Therapeutics

University Hospitals Seidman Cancer Center opened

On Jun. 6, 2011, University Hospitals (UH) Seidman Cancer Center, Northeast Ohio’s first and only freestanding cancer hospital,…

Read More University Hospitals Seidman Cancer Center openedContinue

Roskamp Institute selected for funding by European Commission for a large-scale clinical trial on Nilvadipine
Biotechnology | Neurology | Non-Profit Research | Therapeutics

Roskamp Institute selected for funding by European Commission for a large-scale clinical trial on Nilvadipine

On May 25, 2011, the Roskamp Institute and an international research consortium led by Trinity College Dublin, were…

Read More Roskamp Institute selected for funding by European Commission for a large-scale clinical trial on NilvadipineContinue

Sandia and Cray tackled big data in new supercomputing institute
Biotechnology | Diagnostics | Energy | Genomics | Medical Device | Non-Profit Research | Therapeutics

Sandia and Cray tackled big data in new supercomputing institute

On May 20, 2011, Sandia and supercomputer manufacturer Cray Inc. announced they had signed a cooperative research and…

Read More Sandia and Cray tackled big data in new supercomputing instituteContinue

The University of Minnesota Masonic Children’s Hospital opened a new, innovative building for mothers and children
Biotechnology | Diagnostics | Disease | Medicine | Non-Profit Research | Therapeutics | Women's Health

The University of Minnesota Masonic Children’s Hospital opened a new, innovative building for mothers and children

On Apr. 30, 2011, The University of Minnesota Masonic Children’s Hospital opened a new, innovative building for mothers…

Read More The University of Minnesota Masonic Children’s Hospital opened a new, innovative building for mothers and childrenContinue

Governor Mary Fallin dedicated OMRF’s new 186,000 square foot research tower
Biotechnology | Medicine | Non-Profit Research | Therapeutics

Governor Mary Fallin dedicated OMRF’s new 186,000 square foot research tower

On Apr. 21, 2011, Governor Mary Fallin dedicated the Oklahoma Medical Research Foundation’s (OMRF) new 186,000 s.f. research…

Read More Governor Mary Fallin dedicated OMRF’s new 186,000 square foot research towerContinue

Jon M and Karen Huntsman donated $41 million to cancer research at Huntsman Cancer Institute
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Radiology | Therapeutics

Jon M and Karen Huntsman donated $41 million to cancer research at Huntsman Cancer Institute

On Apr. 21, 2011, Jon M. and Karen Huntsman donated $41 million to cancer research at Huntsman Cancer…

Read More Jon M and Karen Huntsman donated $41 million to cancer research at Huntsman Cancer InstituteContinue

Siemens introduced Aquaris, the world’s first waterproof, dust proof, and shock-resistant digital hearing aid
Medical Device | Therapeutics

Siemens introduced Aquaris, the world’s first waterproof, dust proof, and shock-resistant digital hearing aid

On Apr. 5, 2011, Siemens, now Sivantos, introduced Aquaris, the world’s first waterproof, dust proof, and shock-resistant digital…

Read More Siemens introduced Aquaris, the world’s first waterproof, dust proof, and shock-resistant digital hearing aidContinue

OMRF’s Multiple Sclerosis Center of Excellence opened its doors
Biotechnology | Disease | Therapeutics

OMRF’s Multiple Sclerosis Center of Excellence opened its doors

On Mar. 15, 2011, the Oklahoma Medical Research Foundation’s Multiple Sclerosis Center of Excellence, led by Dr. Gabriel…

Read More OMRF’s Multiple Sclerosis Center of Excellence opened its doorsContinue

Gilead Sciences acquired Calistoga Pharmaceuticals for $375 Million
Biotechnology | FDA | Life Science History | Oncology | Pharmaceutical | Therapeutics

Gilead Sciences acquired Calistoga Pharmaceuticals for $375 Million

On Feb. 22, 2011, Foster City, Calif-based Gilead Sciences and Calistoga Pharmaceuticals announced Gilead’s acquisition of Calistoga for…

Read More Gilead Sciences acquired Calistoga Pharmaceuticals for $375 MillionContinue

Sanofi-aventis acquired Genzyme for $21 billion
Biotechnology | Diagnostics | Pharmaceutical | Therapeutics

Sanofi-aventis acquired Genzyme for $21 billion

On Feb. 15, 2011, Sanofi-aventis announced it would acquired Genzyme for $74 a share in cash or $21.1…

Read More Sanofi-aventis acquired Genzyme for $21 billionContinue

UCSF stem cell building was opened, a milestone for the pioneering program
Biotechnology | Diagnostics | Genomics | Stem Cell | Therapeutics

UCSF stem cell building was opened, a milestone for the pioneering program

On Feb. 9, 2011, the University of California, San Francisco (UCSF) celebrated the official opening of the Ray…

Read More UCSF stem cell building was opened, a milestone for the pioneering programContinue

Stanford Medicine researchers used skin cells from patients with a severe genetic heart defect to create human heart cells with the same genetic mutation
Biotechnology | Genomics | Therapeutics

Stanford Medicine researchers used skin cells from patients with a severe genetic heart defect to create human heart cells with the same genetic mutation

On Feb. 9, 2011, Stanford researchers used skin cells from patients with a severe genetic heart defect to…

Read More Stanford Medicine researchers used skin cells from patients with a severe genetic heart defect to create human heart cells with the same genetic mutationContinue

First international collaboration on Alzheimer’s disease genetics was launched
Biotechnology | Diagnostics | Disease | Neurology | Therapeutics

First international collaboration on Alzheimer’s disease genetics was launched

On Jan. 31, 2011, the first international collaboration on Alzheimer’s disease genetics was launched. The International Genomics of…

Read More First international collaboration on Alzheimer’s disease genetics was launchedContinue

Cardiac Science acquired by Opto Circuits of India for $55 million
Disease | Medical Device | Therapeutics

Cardiac Science acquired by Opto Circuits of India for $55 million

On Dec. 3, 2010, Banglore, India-based Opto Circuits announced completion of its merger with Bothell-based Cardiac Science Corp….

Read More Cardiac Science acquired by Opto Circuits of India for $55 millionContinue

Jane and Lee Seidman donated $42 million to University Hospitals for Cancer Center
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Radiology | Therapeutics

Jane and Lee Seidman donated $42 million to University Hospitals for Cancer Center

On Nov. 30, 2010, Jane and Lee Seidman have donated $42 million to University Hospitals (UH) – the…

Read More Jane and Lee Seidman donated $42 million to University Hospitals for Cancer CenterContinue

Page navigation

Previous PagePrevious 1 … 62 63 64 65 66 … 106 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search